Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Outset Medical, Inc. (OM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
08/02/2023 8-K Quarterly results
Docs: "Outset Medical, Inc. Condensed Statements of Operations Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Revenue: Product revenue $ 29,330 $ 19,621 $ 57,109 $ 45,285 Service and other revenue 6,710 5,436 12,398 10,322 Total revenue 36,040 25,057 69,507 55,607 Cost of revenue: Cost of product revenue 22,212 17,718 43,029 40,828 Cost of service and other revenue 6,125 3,557 12,347 6,555 Total cost of revenue 28,337 21,275 55,376 47,383 Gross profit 7,703 3,782 14,131 8,224 Gross margin 21.4 % 15.1 % 20.3 % 14.8 % Operating expenses: Research and development 14,906 13,521 28,699 24,352 Sales and marketing 24,985 23,198 49,318 43,575 General and administrative 11,290 10,784 23,077 20,493 Total operating expenses 51,181 47,503 101,094 88,420 Loss from operations Inte..."
07/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
06/01/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
02/13/2023 8-K Quarterly results
01/09/2023 8-K Quarterly results
11/08/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
08/01/2022 8-K Quarterly results
Docs: "Outset Medical, Inc. Condensed Statements of Operations Three Months Ended Six Months Ended June 30, June 30, 2022 2021 2022 2021 Revenue: Product revenue $ 19,621 $ 20,628 $ 45,285 $ 38,838 Service and other revenue 5,436 4,588 10,322 9,294 Total revenue 25,057 25,216 55,607 48,132 Cost of revenue: Cost of product revenue 17,718 22,077 40,828 42,654 Cost of service and other revenue 3,557 2,087 6,555 4,137 Total cost of revenue 21,275 24,164 47,383 46,791 Gross profit 3,782 1,052 8,224 1,341 Gross margin 15.1 % 4.2 % 14.8 % 2.8 % Operating expenses: Research and development 13,521 8,032 24,352 15,602 Sales and marketing 23,198 13,204 43,575 26,353 General and administrative 10,784 9,722 20,493 18,968 Total operating expenses 47,503 30,958 88,420 60,923 Loss from operations Other income..."
06/13/2022 8-K Quarterly results
06/01/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
04/25/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Outset Medical Names Business Leader Dale E. Jones to Board of Directors San Jose, CA – April 25, 2022 –"
02/16/2022 8-K Investor presentation, Quarterly results
Docs: "Outset Medical, Inc. Condensed Statements of Operations Three Months Ended Years Ended December 31, December 31, 2021 2020 2021 2020 Revenue: Product revenue $ 23,650 $ 13,177 $ 84,312 $ 39,612 Service and other revenue 4,502 4,070 18,290 10,323 Total revenue 28,152 17,247 102,602 49,935 Cost of revenue: Cost of product revenue 21,459 14,917 84,639 57,035 Cost of service and other revenue 3,372 1,913 10,355 5,937 Total cost of revenue 24,831 16,830 94,994 62,972 Gross profit 3,321 417 7,608 Gross margin 11.8 % 2.4 % 7.4 % % Operating expenses: Research and development 11,410 7,784 36,741 28,850 Sales and marketing 22,991 15,198 65,070 45,068 General and administrative 9,719 9,050 36,316 30,512 Total operating expenses 44,120 32,032 138,127 104,430 Loss from operations Other income : Int...",
"CURRENT STATE ACUTE CHRONIC CLINIC 2019"
11/03/2021 8-K Quarterly results
Docs: "Outset Medical, Inc. Condensed Statements of Operations Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Revenue: Product revenue $ 21,824 $ 10,812 $ 60,662 $ 26,435 Service and other revenue 4,494 2,944 13,788 6,253 Total revenue 26,318 13,756 74,450 32,688 Cost of revenue: Cost of product revenue 20,526 17,265 63,180 42,118 Cost of service and other revenue 2,846 1,617 6,983 4,024 Total cost of revenue 23,372 18,882 70,163 46,142 Gross profit 2,946 4,287 Gross margin 11.2 % % 5.8 % % Operating expenses: Research and development 9,729 9,175 25,331 21,066 Sales and marketing 15,726 13,344 42,079 29,870 General and administrative 7,629 13,088 26,597 21,462 Total operating expenses 33,084 35,607 94,007 72,398 Loss from operations Other income : Interest..."
08/05/2021 8-K Quarterly results
Docs: "Outset Medical Reports Second Quarter 2021 Financial Results 2021 Revenue Guidance Range Updated to $97 million to $100 million",
"Outset Medical Names Nabeel Ahmed as Chief Financial Officer"
07/01/2021 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Securities registered pursuant to Section 12 of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.001 par value per share OM The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as ...",
"Outset Medical Announces Departure of CFO and Appointment of Nabeel Ahmed as Interim CFO"
06/04/2021 8-K Quarterly results
05/24/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
04/13/2021 8-K Quarterly results
04/06/2021 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : April 6, 2021 Outset Medical, Inc. Delaware 001-39513 20-0514392 3052 Orchard Dr. San Jose, California 95134 231-8200 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) ...",
"Outset Medical Announces Primary and Secondary Offering of Common Stock"
03/24/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Outset Medical Appoints Global Consumer Brand Builder Andrea Saia to Board of Directors"
03/09/2021 8-K Quarterly results
02/22/2021 8-K Quarterly results
01/12/2021 8-K Quarterly results
11/30/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : November 30, 2020 Outset Medical, Inc. Delaware 001-39513 20-0514392 3052 Orchard Dr. San Jose, California 95134 231-8200 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Ac...",
"Outset Medical Announces Secondary Offering of Common Stock"
11/12/2020 8-K Quarterly results
Docs: "Outset Medical Reports Third Quarter 2020 Financial Results Strong Quarter Driven by Accelerating Acute Market Penetration and Significant Margin Expansion",
"Earnings Call Transcript"
10/09/2020 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy